Bio-Techne's Select Fetal Bovine Serum Product Rights, Inventory Acquired by Gemini Bioproducts

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.94 USD | -1.12% |
|
-12.09% | -8.45% |
Feb. 06 | Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on February 1, 2022. | CI |
Feb. 06 | Scotiabank Adjusts Bio-Techne's Price Target to $90 From $88 | MT |